US Patent Issued to MOR RESEARCH APPLICATIONS on July 8 for "TREM2 antibodies and uses thereof" (Israeli Inventors)

ALEXANDRIA, Va., July 9 -- United States Patent no. 12,351,629, issued on July 8, was assigned to MOR RESEARCH APPLICATIONS LTD. (Ramat Gan, Israel).

"TREM2 antibodies and uses thereof" was invented by Michael Fassler (Ness Ziona, Israel) and Jacob George (Tel Aviv, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides antibodies and antigen-binding fragments thereof that specifically bind to human Triggering Receptor Expressed on Myeloid Cells 2 (TREM2). The anti-TREM2 antibodies or antigen-binding fragments thereof are useful, for example, in detecting TREM2 and in treating neurodegenerative diseases."

The patent was filed on Dec. 10, 2019, under Application No. 17/312,747....